07th week of 2014 patent applcation highlights part 49 |
Patent application number | Title | Published |
20140045902 | NEW TRIAZOLE COMPOUNDS AS POTENTIAL ANTI-INFLAMMATORY AGENTS - The present invention relates to a compound of formula 1 or 2 | 2014-02-13 |
20140045903 | Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex - The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene. | 2014-02-13 |
20140045904 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE EFFECT - Compositions and methods for reducing the flushing effect (cutaneous erythema) of niacin and for treating hyper lipemia and elevated triglycerides, comprising a prenylflavonoid, such as xanthohumol, and niacin (nicotinic acid or Vitamin B3). | 2014-02-13 |
20140045905 | SYNERGISTIC ANTIMICROBIAL COMPOSITION - A synergistic antimicrobial composition containing 3-iodo-2-propynyl-butylcarbamate and fluometuron. | 2014-02-13 |
20140045906 | NEPRILYSIN INHIBITORS - In one aspect, the invention relates to compounds having the formula: | 2014-02-13 |
20140045907 | Use of Inhibitors of the Renin-Angiotensin System - It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects. | 2014-02-13 |
20140045908 | HSP90 INHIBITORY COMPOUNDS IN TREATING JAK/STAT SIGNALING-MEDIATED CANCERS - Methods for treating a subject with cancer mediated through dysregulated, aberrant, or defective JAK/STAT signaling, are provided, comprising determining the level of the JAK/STAT signaling in a sample derived from a subject in need of treatment, wherein the presence of dysregulated, aberrant, or defective JAK/STAT signaling is indicated, administering to the subject an effective amount of a triazolone compound as described herein. | 2014-02-13 |
20140045909 | DENIBULIN DI-HYDROCHLORIDE - MN-029 di-hydrochloride (MN-029.2HCl, Formula 2) is a potent vascular targeting agent. | 2014-02-13 |
20140045910 | NOVEL AMINO-PYRROLINE DERIVATIVES, AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME - Novel amino-pyrrolinic derivatives, their pharmacologically acceptable salts and use thereof in the prevention and/or treatment of metabolic syndrome. | 2014-02-13 |
20140045911 | Phenoxy-Pyrrolidine Derivative and Its Use and Compositions - The present invention is directed to the compound 2-(4-(hydroxymethyl)phenoxy)-1-(3-(2-(trifluoromethyl)phenoxy)pyrrolidin-1-yl)ethanone, its use as an inhibitor of stearoyl CoA desaturase and to pharmaceutical compositions containing this compound. | 2014-02-13 |
20140045912 | COMPOSITION AND METHOD FOR TREATMENT OF DIABETES - The present invention relates to a method of treating diabetes type II by delivery of butyric acid, bile acid, long chain fatty acid or glutamine to the colon by bypassing the upper digestive tract. The composition is combined either by the same or different route of administration with a DPP-IV inhibitor such as vildagliptin. | 2014-02-13 |
20140045913 | LIPID NANO PARTICLES COMPRISING COMBINATION OF CATIONIC LIPID - The present invention provides a lipid nano-particles, which allow nucleic acids to be easily introduced into cells, comprising a cationic lipid represented by formula (I)
| 2014-02-13 |
20140045914 | RECOMBINANT PROTEIN FOR SIRNA DELIVERY AND COMPOSITION COMPRISING THE SAME - This invention relates to a recombinant protein for siRNA delivery and a composition comprising the same. The recombinant proteins for siRNA delivery of the invention can secure the stability of siRNAs from external attacks such as various degradation enzymes, have selective binding affinity to cancer cells by virtue of target-oriented peptides having various cancer cells as their target, and silence target genes by effectively delivering the siRNAs to cells and biological tissues by the release of the siRNAs to the cytoplasms after the cell penetration thereof. Therefore, they are expected to be effectively employed as siRNA delivery vehicles for siRNA therapeutic agents, cell-based drug screening compositions and research. | 2014-02-13 |
20140045915 | CANCER-RELATED BIOLOGICAL MATERIALS IN MICROVESICLES - Disclosed herein are methods for assaying a biological sample from a subject by analyzing components of microvesicle fractions in aid of risk, diagnosis, prognosis or monitoring of or directing treatment of the subject for, a disease or other medical condition in the subject. Also disclosed are methods of treatment and identifying biomarkers using a microvesicle fraction of a subject. Kits, pharmaceutical compositions, and profiles related to the methods are also disclosed. | 2014-02-13 |
20140045916 | SPLICE-REGION ANTISENSE COMPOSITION AND METHOD - Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5′ end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein. | 2014-02-13 |
20140045917 | Composition Containing Antisense Oligonucleotide to Micro RNA - Provided is a composition that contains an antisense oligonucleotide to a micro RNA and is capable of inhibiting the growth of cancer cells. The present invention, as one aspect, relates to a composition for suppressing the growth of human cancer cells, the composition containing an antisense oligonucleotide to a micro RNA, wherein the micro RNA is selected from the group consisting of hsa-miR-133a, hsa-miR-133b, hsa-miR-346 and hsa-miR-361-3p. The present invention, as another aspect, relates to a composition for suppressing the growth of human head/neck cancer cells, the composition containing an antisense oligonucleotide to a micro RNA, wherein the micro RNA is selected from the group consisting of hsa-miR-92a, hsa-miR-133a, hsa-miR-133b, hsa-miR-139-5p, hsa-miR-197, hsa-miR-328, hsa-miR-346, hsa-miR-361-3p, hsa-miR-605, hsa-miR-766, hsa-miR-1228, hsa-miR-1252, hsa-miR-1260 and hsa-miR-1271. | 2014-02-13 |
20140045918 | Materials and Methods Related to MicroRNA-21, Mismatch Repair, and Colorectal Cancer - The present invention discloses the discovery that miR-21 targets and down-regulates the core mismatch repair (MMR) recognition protein complex hMSH2 and hMSH6. Anti-sense miR-21 is therefore proven as therapeutic herein. Therefore, compositions, kits, therapies and other methods, including methods of treatment/amelioration of symptoms, are disclosed in the present invention. | 2014-02-13 |
20140045919 | Folate Conjugates - The present invention provides iRNA agent including at least one monomer having the structure shown in formula (I′) | 2014-02-13 |
20140045920 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, CLASSIFICATION, AND TREATMENT OF CANCER - Some embodiments of the present technology relate to methods and compositions for the diagnosis and treatment of cancer. Some embodiments include methods and compositions for the diagnosis and treatment of castration-resistant prostate cancer. Some embodiments include methods and compositions for the diagnosis and treatment of pancreatic cancer. | 2014-02-13 |
20140045921 | TRANSCRIPTIONAL REPRESSION LEADING TO PARKINSON'S DISEASE - Parkinson's disease is caused by the preferential loss of substantia nigra dopamine neurons. A Parkin Interacting Substrate, PARIS (ZNF746) is identified. The levels of PARIS are regulated by the ubiquitin proteasome system via binding to and ubiquitination by the E3 ubiquitin ligase, parkin. PARIS is a KRAB and zinc finger protein that accumulates in models of parkin inactivation and in human brain Parkinson's disease patients. PARIS represses the expression of the transcriptional co-activator, PGC-1α and the PGC-1α target gene, NRF-1 by binding to insulin response sequences in the PGC-1α promoter. Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons that is PARIS dependent. Overexpression of PARIS causes selective loss of DA neurons in the substantia nigra, which is reversed by either parkin or PGC-1α co-expression. The identification of PARIS provides a molecular mechanism for neurodegeneration due to parkin inactivation. | 2014-02-13 |
20140045922 | RNAi Modulation Of ApoB And Uses Thereof - The invention relates to compositions and methods for modulating the expression of apolipoprotein B, and more particularly to the downregulation of apolipoprotein B by chemically modified oligonucleotides. | 2014-02-13 |
20140045923 | GENE THERAPY COMPOSITIONS FOR PREVENTING AND/OR TREATING OF AUTOIMMUNE DISEASES - Gene therapy compositions for the prevention and/or treatment of autoimmune diseases. The present invention relates to vectors, preferably plasmids that comprise specific promoters, that encode insulin-like growth factor I (IGF-I) or a functional biological equivalent thereof, which will be used to prevent or treat Type 1 Diabetes (DT1) and/or other autoimmune diseases. Moreover, the invention comprises the method of preventing or treating DT1 by means of the expression of IGF-I, or a functional biological equivalent thereof, in hepatic cells. IGF-I was capable of interrupting the immune attack against pancreatic β cells, thereby preventing the loss of β cell mass and, consequently, maintaining normal levels of circulating insulin. | 2014-02-13 |
20140045924 | MELANOMA TREATMENTS - Provided herein, in some embodiments, are methods for treating melanoma, improving therapeutic effectiveness of drugs and reducing drug toxicity. | 2014-02-13 |
20140045925 | RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN - The present invention relates to RNA interference-based methods for inhibiting the expression of the myotilin gene. Recombinant adeno-associated viruses of the invention deliver DNAs encoding microRNAs that knock down the expression of myotilin. The methods have application in the treatment of muscular dystrophies such as Limb Girdle Muscular Dystrophy Type 1A. | 2014-02-13 |
20140045926 | CRYSTALLINE FORMS OF CABAZITAXEL - The present invention provides crystalline forms, including an anhydrate form, of cabazitaxel and processes for the preparation of these forms, designated as Forms C1, C2, C3, C4, C5, C6, C7, C8, C8b, C9 and C9p. | 2014-02-13 |
20140045927 | PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF - The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip. The preparation of the present invention does not contain solubilizer and has advantages of little toxicity, safety, effectiveness, stability and economy. The fat emulsion is also used as a nutritional replenishment, thus achieving a better therapeutic effect. In addition, the normal saline or glucose solution for injection can be used to replace a considerable amount of the emulsion, which makes the preparation, therefore, not only cost-efficient, but also convenient for transportation and storage in practice. | 2014-02-13 |
20140045928 | POLYPHENOL/THEANINE COMPOSITIONS - Disclosed herein are compositions comprising tea derived components which are useful in reducing the incidence of cold and/or flu in a subject. Specifically exemplified herein are compositions comprising predetermined amounts of L-theanine and EGCG, and methods of using same. | 2014-02-13 |
20140045929 | CHROMAN-DERIVED ANTI-ANDROGENS FOR TREATMENT OF ANDROGEN MEDIATED DISORDERS - Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer. | 2014-02-13 |
20140045930 | ASSAY FOR ARGINYL HYDROXYLASE ACTIVITY - The present invention relates to assays for monitoring activity of YcfD activity, in particular, to assays for identifying modulators of YcfD activity. The present invention also relates to the use of YcfD inhibitors as antibiotics. The invention also relates to methods for introducing hydroxyarginine residues into proteins. | 2014-02-13 |
20140045931 | POLYPHENOL PROTEASOME INHIBITORS, SYNTHESIS, AND METHODS OF USE - The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers. | 2014-02-13 |
20140045932 | FLAVANOL AND CAROTENOID COMPOSITIONS - This invention relates to compositions containing polyphenols, for example, cocoa polyphenols such as flavanols and their related oligomers, and methods for treating abnormalities in gap junctional communication of cells, such as cancer, heart arrhythmia, neuro-degenerative diseases and cognitive dysfunction. | 2014-02-13 |
20140045933 | METHODS AND COMPOSITIONS FOR TREATING METABOLIC SYNDROME - Provided are methods, compositions, systems, and kits for treating metabolic syndrome or a disorder associated with metabolic syndrome, e.g., obesity, dyslipidemia, and/or a diabetic condition, comprising administering systemically to a subject one or more compounds of the Formula (I) and/or (II): or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, polymorph, tautomer, isotopically enriched derivative, or prodrug thereof, wherein, L, R | 2014-02-13 |
20140045934 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g., a MetAP-2 inhibitor. | 2014-02-13 |
20140045935 | Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol - The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a MetAP-2 inhibitor. | 2014-02-13 |
20140045936 | CYCLOPROPYL DERIVATIVES AND METHODS OF USE - The disclosure relates to cyclopropyl derivatives and methods of use. In some embodiments, the disclosure relates to methods of managing medical disorders with pharmaceutical compositions disclosed herein administered to subject in need thereof. In certain embodiments, the disclosure relates to methods of managing mental disorders, mood disorders, pain, and fibromyalgia and related conditions with pharmaceutical compositions disclosed herein. | 2014-02-13 |
20140045937 | METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID - The invention provides a method of treating or preventing polycystic ovarian syndrome (PCOS) in a mammal, comprising administering chlorogenic acid in an amount effective to treat or prevent PCOS in the mammal. In an embodiment of the invention, the method further comprises administering L-cysteine to the mammal. | 2014-02-13 |
20140045938 | Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth - Disclosed are methods and pharmaceutical compositions for modulating one or more steroidal receptor activities. The methods typically utilize and the pharmaceutical compositions typically include one or more substituted phenyl aziridine precursors, their respective aziridines, analogs thereof, derivatives thereof, or pharmaceutically acceptable salts thereof such as CpdA. The methods and compositions may be used for treating diseases, disorders, and conditions associated with glucocorticoid receptor activity, androgen receptor activity, or both, such as cancers, acne vulgaris, and alopecia. | 2014-02-13 |
20140045939 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES - Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery. | 2014-02-13 |
20140045940 | OIL BODY EXTRACTION AND USES - The present invention provides a method of extracting naturally occurring oil bodies comprising obtaining material containing naturally occurring oil bodies, recovering the oil bodies in a wet preparation and drying the oil bodies; and dried oil bodies obtained by the method and uses thereof. | 2014-02-13 |
20140045941 | PLANT DERIVED SEED EXTRACT RICH IN ESSENTIALLY FATTY ACIDS DERIVED FROM SALVIA HISPANICA L. SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE | 2014-02-13 |
20140045942 | TOPICAL COMPOSITION - The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved. | 2014-02-13 |
20140045943 | Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof - Disclosed are amino alkyl/aryl hydroxamic acid compounds and pharmaceutical compositions containing such compounds. The disclosed compositions are useful as therapeutics for degenerative diseases in mammal. | 2014-02-13 |
20140045944 | SYNERGISTIC ANTIMICROBIAL COMPOSITION - A synergistic antimicrobial composition containing 3-iodo-2-propynyl-butylcarbamate and fluometuron. | 2014-02-13 |
20140045945 | INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS - Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye. | 2014-02-13 |
20140045946 | Compositions and Methods for Treatment of Glaucoma - A new use for paracetamol in a method of treating glaucoma, which method comprises administering to a patient in need of such treatment 500 mg to 1000 mg of paracetamol in oral format 4 to 6 hourly. An ophthalmic solution is also provided containing between 0.1 to 5% of paracetamol which is administered as one to two drops in each eye 4 to 6 hourly. The ophthalmic solution further includes one or more of the following excipients: hydroxypropylmethylcellulose, benzalconium chloride, polyacrylic acid such as Teargel®. | 2014-02-13 |
20140045947 | Methods for Maintaining or Improving Health, Well-Being and/or a Physiological Function in a Subject - The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. The invention further relates to a method of improving a physiological function in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. | 2014-02-13 |
20140045948 | KIT OF OPHTHALMIC COMPOSITION - An ophthalmic composition kit comprising an ophthalmic container holding an ophthalmic composition comprising geranylgeranylacetone, the ophthalmic container having a surface in contact with the ophthalmic composition, the surface being at least partially or wholly made of a container material selected from the group consisting of a polyolefin, an acrylic acid resin, a terephthalic acid ester, a polycarbonate, a polymethylterpene, a fluorine resin and a glass, the ophthalmic composition kit having an advantage that the loss of the geranylgeranylacetone content or decrease in the geranylgeranylacetone concentration in the ophthalmic composition is very little. | 2014-02-13 |
20140045949 | METHOD FOR FORMING DROPS OF A FIRST PHASE, DISPERSED IN A SECOND PHASE SUBSTANTIALLY IMMISCIBLE WITH THE FIRST PHASE - This method includes the provision of a first fluid ( | 2014-02-13 |
20140045950 | DRUG DELIVERY VEHICLE - The invention provide herein provides for a targeted drug delivery vehicle compositions, methods of manufacture, and methods of treatment for therapeutic applications. | 2014-02-13 |
20140045951 | SYNTHETIC VITREOUS MATERIAL - A synthetic vitreous material contains a self-assembling peptide and a salt, and has an osmotic pressure of 40 mOsm/kg to 200 mOsm/kg. Such a synthetic vitreous material is not toxic to ocular tissue, is capable of maintaining an intraocular tamponade effect over a long term, and is easy to handle and inject into an eye of a patient. | 2014-02-13 |
20140045952 | CATALYSTS - A process for preparing a catalyst precursor includes forming a slurry of particles of an insoluble metal compound, where the metal of the insoluble metal compound is an active catalyst component, with particles and/or one or more bodies of a pre-shaped catalyst support in a carrier liquid. The particles of the insoluble metal compound are thus contacted with the particles and/or the one or more bodies of the pre-shaped catalyst support. A treated catalyst support is thereby produced. Carrier liquid is removed from the slurry to obtain a dried treated catalyst support, which either directly constitutes the catalyst precursor, or is optionally calcined to obtain the catalyst precursor. | 2014-02-13 |
20140045953 | TREATING OF CATALYST SUPPORT - A method for the preparation of a modified catalyst support comprising: (a) treating a catalyst support material with an aqueous solution or dispersion comprising one or more zirconium metal sources, chromium metal sources, manganese metal sources and aluminium metal sources, and one or more polar organic compounds; and (b) drying the treated support, and (c) optionally calcining the treated support. Also provided are catalyst support materials obtainable by the methods, and catalysts prepared from such supports. | 2014-02-13 |
20140045954 | FISCHER-TROPSCH PROCESS - The disclosed invention relates to a process for conducting a Fischer-Tropsch reaction, comprising flowing a reactant mixture comprising fresh synthesis gas and tail gas in a microchannel reactor in contact with a catalyst to form at least one hydrocarbon product, the catalyst being derived from a catalyst precursor comprising cobalt and a surface modified catalyst support. | 2014-02-13 |
20140045955 | METHOD OF MANUFACTURING OLEFIN HAVING 2 TO 4 CARBON ATOMS BY FISCHER-TROPSCH REACTION - Provided are a method of manufacturing an olefin having 2 to 4 carbon atoms including: reacting a catalyst with synthesis gas through a Fischer-Tropsch reaction, thereby obtaining the olefin having 2 to 4 carbon atoms, in which the catalyst is a catalyst obtained by reducing the iron ion and the cobalt ion in a dispersion liquid or a solution containing the iron ion, the cobalt ion and a dispersant that interacts with the iron ion and the cobalt ion, and a method of manufacturing propylene, which uses the above manufacturing method. | 2014-02-13 |
20140045956 | HYDROPHILIZING AGENT COMPOSITION, HYDROPHILIZING METHOD, HYDROPHILIZED RESIN POROUS MATERIAL AND ITS PRODUCTION METHOD - A hydrophilizing agent composition comprising a copolymer having an alternating copolymerization ratio of repeating units represented by the following formula (1) and repeating units represented by the following formula (2) of at least 95%, and a solvent: | 2014-02-13 |
20140045957 | METHOD FOR MANUFACTURING DISPERSION OF HOLLOW PARTICLES, METHOD FOR MANUFACTURING ANTIREFLECTIVE FILM, AND METHOD FOR MANUFACTURING OPTICAL ELEMENT - A method for manufacturing a dispersion of hollow particles includes producing a core-shell type particle by forming a shell made mainly of an inorganic-based compound on a surface of a particle made mainly of an organic compound in an aqueous medium, and obtaining the dispersion of the hollow particles formed of the shell by hydrophobizing the core-shell type particles and extracting the core-shell type particles with an aromatic organic solvent. | 2014-02-13 |
20140045958 | TREATED INORGANIC PIGMENTS HAVING IMPROVED BULK FLOW AND THEIR USE IN POLYMER COMPOSITIONS - The disclosure provides a polymer composition comprising a treated inorganic pigment, wherein the treated inorganic pigment comprises an inorganic pigment comprising a pigment surface area of about 30 to about 75 m | 2014-02-13 |
20140045959 | FLUORINATED ELASTOMER COMPOSITION AND FLUORINATED FOAMED RUBBER - To provide a fluorinated elastomer composition which can improve, in production of a fluorinated foamed rubber by foaming and crosslinking a fluorinated elastomer using an organic peroxide as a crosslinking agent, the foamed state and physical properties of the fluorinated foamed rubber. | 2014-02-13 |
20140045960 | POLYURETHANE FOAM AND METHOD FOR PRODUCING SAME - A polyurethane foam is obtainable from the reaction of a mixture comprising A) an isocyanate-reactive compound; B) a blowing agent selected from the group comprising linear, branched or cyclic C | 2014-02-13 |
20140045961 | STYRENIC RESIN HAVING IMPROVED EXTENSIONAL VISCOSITY - The extensional viscosity of a styrenic resin is enhanced by increasing the Z+1 average molecular weight (Mz+1) of the resin. In one embodiment, an enhanced extensional viscosity resin is provided that has an Mz+1 molecular weight of at least approximately 745,000 and an extensional viscosity having a minimum value of approximately 360,000 Pascal-seconds (Pa-sec). | 2014-02-13 |
20140045962 | IMPACT ABSORBING FOAM - This invention relates to impact absorbing foams. These foams comprise a polymeric foam and ceramic particulates dispersing the foam. These foams have numerous uses, including, for example, as interior pads for football helmets, and the like, for reducing head injuries. | 2014-02-13 |
20140045963 | PHOTOCURABLE COMPOSITION - [Problem] To provide a photocurable sealing material which exhibits stable physical properties, particularly permanent compression set when subjected to a heat resistance test in an atmosphere of 100 to 150° C., and has a stable applying shape and storage stability. | 2014-02-13 |
20140045964 | METHOD FOR MANUFACTURING AN ADHESIVE BOND OR COMPOSITE AND ADHESIVE OR MATRIX MATERIAL SUITABLE FOR THIS PURPOSE - The present invention relates to a method for manufacturing an adhesive bond between two components, in which an adhesive is used that can be cured with at least two different curing mechanisms. A first curing mechanism here generates less stiffness in the adhesive than at least one second curing mechanism. The layer of adhesive applied to join the components is cured with the first curing mechanism in the region between the components over the entire layer and with the at least second curing mechanism only locally, so that the stiffness of the adhesive layer varies in the region between the components. In like manner, a composite or composite layer can be manufactured with a matrix material, in which the matrix material is varyingly locally cured. The invention also relates to an adhesive or matrix material suitable for the method. The material and accompanying method can be used for many applications. | 2014-02-13 |
20140045965 | ACTIVE RAY-CURABLE COMPOSITION, AND ACTIVE RAY-CURABLE INKJET PRINTING INK COMPOSITION AND ACTIVE RAY-CURABLE ADHESIVE COMPOSITION USING THE SAME - An active ray-curable composition characterized by containing a photobase generator, a double bond-containing compound, and a β-dicarbonyl compound. | 2014-02-13 |
20140045966 | PHOTOSENSITIVE COMPOSITION. CURED ARTICLE, AND METHOD FOR PRODUCING ACTINICALLY CURED ARTICLE - The photosensitive composition of the present invention includes: (1) a radical initiator (A); (2) an acid generator (B) and/or a base generator (C); and (3) a polymerizable substance (D), wherein at least one of the radical initiator (A), the acid generator (B) and the base generator (C) are to generate an active species (H) on exposure to active rays, the active species (H) reacting with the radical initiator (A), the acid generator (B) or the base generator (C) to generate another active species (I), the active species (I) initiating polymerization of the polymerizable substance (D), the active species (H) or (I) is an acid or a base, and the photosensitive composition contains substantially no colorants, metal oxide powder, or metallic powder. | 2014-02-13 |
20140045967 | NEW PROSTHETIC DEVICES - A prosthetic device made of a first specific type of polyarylene, taken alone or in combination with a second specific type of polyarylene, featuring some unexpected advantages such as a very high strength and stiffness, good elongation properties, high chemical resistance, good biocompatibility as well as an outstanding impact resistance. | 2014-02-13 |
20140045968 | NON-PAINTING AND HIGH-GLOSS POLYCARBONATE RESIN COMPOSITION - The invention provides a non-painting and high-gloss polycarbonate resin composition. Specifically, the invention provides a polycarbonate resin composition having a superior impact strength, heat-resistance, electric characteristics, weather resistance, and light resistance. In certain embodiments, the resin composition of the invention is obtained by mixing a butadiene-based impact modifier, such as acrylonitrile-butadiene-styrene (ABS) or methacrylate-butadiene-styrene and an acryl-based impact modifier in polycarbonate resin, followed by adding an ultraviolet (UV) absorbent to the mixture. | 2014-02-13 |
20140045969 | Curable Composition - The invention relates to a composition comprising (A) at least 5% by weight of en organic prepolymer P having at least two water-crossilnkable organosilicon end groups, (B) 0.01% to 3.0% by weight of boric acid and/or bone ester, and (C) 0.01% to 3.0% by weight of an amine component. Additionally disclosed is a method for the curing of these compositions and also the use of boric acid and/or boric esters and an amine component a condensation catalyst. | 2014-02-13 |
20140045970 | SYNERGISTIC ANTIMICROBIAL COMPOSITION - A synergistic antimicrobial composition containing 3-iodo-2-propynyl-butylcarbamate and fluometuron. | 2014-02-13 |
20140045971 | SYNERGISTIC ANTIMICROBIAL COMPOSITION - A synergistic antimicrobial composition containing 3-iodo-2-propynyl-butylcarbamate and fluometuron. | 2014-02-13 |
20140045972 | METHOD FOR PREPARING INSULATING VARNISH - A method for preparing an insulating varnish. The method includes: providing equivalence of an epoxy resin solution having a concentration exceeding 99 wt. % and acetone solution having a concentration of 40 wt. %, adding silane coupling agent-modified hexagonal boron nitride (BN) having a particle size of between 200 and 250 nm to the acetone solution and stirring; mixing the epoxy resin solution and the acetone solution and stirring, and dispersing the resulting mixture; adding to the mixture, low molecular weight polyamide resins as a curing agent, and stirring to uniformly disperse the curing agent; adding n-butane as a lubricant to the mixture and stirring, cooling the mixture to room temperature, adding di-n-butyl phthalate as a diluent to the mixture and stirring; and allowing the mixture to stand in a vacuum drier to remove bubbles to yield the insulating varnish, which is free of bubbles. | 2014-02-13 |
20140045973 | TRIMETHYL BORATE IN EPOXY RESINS - A composition comprising a polyepoxide, a hardener, trimethyl borate, and a flame retardant is disclosed. Methods for preparing the composition and its end uses are also disclosed. | 2014-02-13 |
20140045974 | OIL IN WATER EMULSION - The present invention relates to an oil-in-water emulsion, wherein the oil comprises an acid functional unsaturated polyester which acid functional unsaturated polyester comprises unsaturated dicarboxylic acid units, diol units, units of an emulsifier with HLB value of from 9 to 20 and further comprising chain extender units. The present invention further relates to a fibre mat comprising fibres and a binder comprising such acid functional unsaturated polyester. | 2014-02-13 |
20140045975 | METHOD OF PREPARING CROSS-LINKED COLORANT DISPERSIONS - A process for preparing a crossed-linked colorant dispersion is provided in which a pigment and a dispersant polymer having a cross-linkable moiety are subjected to micromedia milling followed by a purification step to remove small pigment particles before reacting the cross-linkable moiety on the dispersant polymer with a cross-linking agent. Also disclosed is the use of dispersions made from this process in ink jet inks. | 2014-02-13 |
20140045976 | Fluid Activatable Adhesives and Fluids for Activating Same for Use With Liner-Free Labels - Fluid activatable adhesive compositions and activating fluid(s) for activating the adhesive composition are described herein. The adhesive compositions contain at least two polymers with different hydrophilicities. The hydrophilic polymer has quick tack when exposed to a hydrophilic solvent, such as water or other aqueous solvent, while the hydrophobic polymer provides strong adhesion to a paper or polymeric substrate. The adhesive composition may contain particulate fillers which enable fast exhaustion of the activation fluid out of the adhesive when applied to a substrate, thereby allowing the hydrophobic polymers of the adhesive composition to achieve strong adhesion of the liner-free label to the paper or polymeric substrate. The particulate fillers may also function as anti-blocking agents when liner-free label media are tightly wound in a roll. The adhesive compositions described herein may be used not only on paper, cardboard, and metal, but also on glass and plastics commonly used in commercial applications. | 2014-02-13 |
20140045977 | NOVEL IONIC LIQUIDS, FUNCTIONALIZED PARTICULATES, AND FLUOROPOLYMER COMPOSITES - The present invention relates to (i) novel fluoroionic compounds capable of dispersing particulate filler compositions into a fluoropolymer; (ii) novel particulate compositions in which particulates are surface-functionalized with a fluoroionic compound; (iii) fluoropolymer composite materials containing the surface-functionalized particulates of (ii) incorporated into a fluoropolymer; (iv) crosslinked versions of (iii); v) methods for producing the crosslinked material of (iv); and (vi) articles of manufacture containing the compositions (iii) and (iv). | 2014-02-13 |
20140045978 | Reinforced PCT Compositions - The invention relates to polymer compositions comprising PCT (poly((cyclohexylene-dimethylene) terephthalate)) polymer and a fibrous glass filler having a non-circular cross-sectional aspect ratio of greater than at or about 4. | 2014-02-13 |
20140045979 | POLY(PHENYLENE ETHER) COMPOSITION AND INJECTION MOLDED ARTICLE THEREOF - A composition having a combination of high heat resistance, high impact strength, and high flame retardance includes specific amounts of poly(phenylene ether), hydrogenated block copolymer, and organophosphate flame retardant. The composition has minimal amounts or excludes certain styrenic polymers, polyolefins, and reinforcing fillers. Also disclosed are injection molded articles formed from the composition. The composition is particularly useful as a molding composition for photovoltaic junction boxes and connectors. | 2014-02-13 |
20140045980 | ADDITIVES FOR HIGH-FLOW POLYMERS - A composition containing (I) a natural or synthetic organic polymer having a melt flow index of 15 to 1000 g/10 min at 230° C. and 2.16 kg and (II) an additive mixture containing components (A1) and (A2), wherein (A1) is at least one organic cyclic phosphoric acid ester of the formula (I) (I) wherein R | 2014-02-13 |
20140045981 | PHOSPHITE COMPOSITIONS - Solid phosphite compositions comprising tris(4-t-alkylphenyl)phosphites and selected hydroxyalkyl amines exhibit surprising performance compared with other phosphite stabilizers in the stabilization of polymers, such as polyolefins and the like, particularly in the prevention of color formation during high temperature processing or when exposed to certain gasses during storage, e.g., “gas fading”. | 2014-02-13 |
20140045982 | FIBROUS BASIC MAGNESIUM SULFATE POWDER AND METHOD FOR PRODUCING SAME - A fibrous basic magnesium sulfate powder which does not contain CO | 2014-02-13 |
20140045983 | COMPOSITE REINFORCER SHEATHED WITH A LAYER OF POLYMER THAT IS SELF-ADHESIVE TO RUBBER - Composite reinforcer (R-2) capable of adhering directly to a diene rubber matrix, which can be used as a reinforcing element for a pneumatic tyre, comprising:
| 2014-02-13 |
20140045984 | Auto-Adhesive Composite Reinforcement - Composite reinforcer (R- | 2014-02-13 |
20140045985 | POLYPROPYLENE RESIN COMPOSITION - A polypropylene resin composition, including 75-90 wt. % of polypropylene resin as a matrix, 7-15 wt. % of hydrogenated styrene-butadiene-styrene copolymer elastomer (A) having a styrene content of 18-42 wt. %, and 3-10 wt. % of hydrogenated styrene-butadiene-styrene copolymer elastomer (B) having a styrene content of 12-15 wt. %. The polypropylene resin composition has an excellent scratch resistance compatible with impact resistance, and outstanding melt-moldability and is suitable for providing a colored-resin molding compound. | 2014-02-13 |
20140045986 | BUTYL IONOMER LATEX - The invention relates to a latex composition wherein the latex composition comprises a butyl ionomer or partially halogenated butyl rubber ionomer. The latex composition is formed by dissolving the butyl ionomer in a suitable solvent, emulsifying the polymer in the solvent, adding water and optionally a minor amount of a suitable surfactant system to the emulsion and concentrating the emulsion to remove the water. The advantages of butyl ionomer latex include lower emulsifier levels, increased latex stability, improved interaction and adhesion to polar substrates and surfaces. Through the judicious choice of emulsifiers and/or washing to remove excess emulsifier a film with enhanced non-extractable polymeric antimicrobial function can be created. These properties of ionomer latex are useful in coatings, dipped goods and sponge applications. | 2014-02-13 |
20140045987 | CURABLE SILICONE RUBBER COMPOSITION AND MEASUREMENT METHOD FOR CURABLE SILICONE RUBBER COMPOSITIONS - The correlation between the aggregation structure of inorganic fillers such as silica microparticles in silicone rubbers and tensile strength and tear strength still has not been elucidated. The purpose of the invention is to provide a curable silicone rubber composition with which a silicone rubber of superior tensile strength and tear strength can be obtained. The invention provides a curable silicone rubber composition that is characterized in that the aggregate size of the inorganic filler prior to extending as determined by synchrotron X-ray diffraction measurement is 20-25 nm and the maximum value for the orientation coefficient of the curable silicone rubber composition when drawn as determined by synchrotron X-ray diffraction measurement is 0.25-0.35. | 2014-02-13 |
20140045988 | NOVEL POLYMER COMPOSITION FOR USE IN BLOW MOULDING - A novel polymer composition is described comprising ethylene homopolymers and/or copolymers of ethylene with C | 2014-02-13 |
20140045989 | ELASTOMER COMPOSITE AND METHOD FOR PRODUCING IT - A method of producing an elastomer composite. The method includes A) combining a first fluid comprising elastomer latex with a second fluid comprising particulate filler; B) causing the elastomer latex to coagulate, thereby forming masterbatch crumb; C) bringing the masterbatch crumb to a water content of about 1 weight percent to about 20 weight percent, thereby forming a dewatered coagulum; D) removing water from the dewatered coagulum by subjecting the dewatered coagulum to mechanical energy, thereby causing the dewatered coagulum to heat as a result of friction, while allowing the dewatered coagulum to achieve a temperature of about 130° C. to about 190° C., wherein water content is reduced to about 0.5% to about 3% and wherein substantially all of the decrease in water content is accomplished by evaporation, thereby producing a masticated masterbatch; and E) subjecting the masticated masterbatch to at least an additional 0.3 MJ/kg of mechanical energy while further reducing the water content. | 2014-02-13 |
20140045990 | OLEFIN-BASED IONOMER RESIN COMPOSITION - The present application relates to an olefin-based ionomer resin composition, to an encapsulant, and to an optoelectronic device. The resin composition according to the present application may be used as an encapsulant for a variety of optoelectronic devices, and may exhibit superior adhesion to the substrates of the optoelectronic devices. In addition, according to the present application, an olefin-based ionomer resin composition, which can provide good workability and economic advantages in the manufacture of devices without negatively affecting components such as encapsulated optoelectronic elements or the wired electrodes of optoelectronic devices, may be provided. | 2014-02-13 |
20140045991 | FLAME RETARDANT NYLON - Technologies are generally described for a system and method effective to prepare a flame retardant. In one example, a method may include copolymerizing a mixture of monomers. The mixture of monomers may include at least one dicarboxylic acid monomer, at least one diamine monomer, and at least one monomer having the formula (I) | 2014-02-13 |
20140045992 | WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE - A water/oil repellent composition comprising a polymer having structural units based on the following monomer (a) and structural units based on the following monomer (b), and an aqueous medium containing water and the following amide solvent (I) is used. Monomer (a): a compound represented by (Z—Y) | 2014-02-13 |
20140045993 | REACTIVE RESINS FOR CABLE SEALING COMPOUNDS - The invention describes a composition, especially in the form of a 2-component system comprising (meth)acrylated polyether polyols and/or polyester polyols and/or (meth)acrylated hydroxy-functionalized triglycerides with an adjustable pot life, especially for cable potting compounds. | 2014-02-13 |
20140045994 | THERMOPLASTIC POLYOLEFINS WITH HIGH FLOWABILITY AND EXCELLENT SURFACE QUALITY PRODUCED BY A MULTISTAGE PROCESS - Reactor grade thermoplastic polyolefins with high flowability and excellent surface quality comprising (A) 40-90 wt % of a propylene homo- or copolymer matrix with an MFR in accordance with ISO 1 133 (230° C., 2.16 kg load) of ≧200 g/10 min and (B) 2-30 wt % of an elastomeric ethylene-propylene copolymer having an intrinsic viscosity IV (according to ISO 1628 with decalin as solvent) of ≦2.8 dl/g and an ethylene content of >50 to 80 wt % and (C) 8-30 wt % of an elastomeric ethylene-propylene copolymer having an intrinsic viscosity IV (according to ISO 1628 with decalin as solvent) of 3.0-6.5 dl/g and an propylene content of 50 to 80 wt %, the reactor grade thermoplastic polyolefins being obtainable by a multistage polymerization process with at least 3 polymerization steps in the presence of a catalyst system comprising (i) a Ziegler-Natta procatalyst which contains a trans-esterification product of a lower alcohol and a phthalic ester and (ii) an organometallic cocatalyst and (iii) external donor represented by formula (I) Si(OCH | 2014-02-13 |
20140045995 | ACRYLIC RESIN FILM - Disclosed herein is an acrylic resin film having excellent heat resistance and mechanical strength, less fish-eyes, and high transparency. The acrylic resin film is obtained by molding a resin composition containing a glutarimide acrylic resin (G) and a (meth)acrylic resin (F) obtained by polymerization of a vinyl group-containing compound in the presence of alkyl acrylate-based cross-linked elastic particles having an average particle size of less than 80 nm. | 2014-02-13 |
20140045996 | LIGNIN-DERIVED THERMOPLASTIC CO-POLYMERS AND METHODS OF PREPARATION - The present invention relates to a crosslinked lignin comprising a lignin structure having methylene or ethylene linking groups therein crosslinking between phenyl ring carbon atoms, wherein said crosslinked lignin is crosslinked to an extent that it has a number-average molecular weight of at least 10,000 g/mol, is melt-processible, and has either a glass transition temperature of at least 100° C., or is substantially soluble in a polar organic solvent or aqueous alkaline solution. Thermoplastic copolymers containing the crosslinked lignin are also described. Methods for producing the crosslinked lignin and thermoplastic copolymers are also described. | 2014-02-13 |
20140045997 | OLEFIN METATHESIS FOR EFFECTIVE POLYMER HEALING VIA DYNAMIC EXCHANGE OF STRONG CARBON-CARBON BONDS - A method of preparing a malleable and/or self-healing polymeric or composite material is provided. The method includes providing a polymeric or composite material comprising at least one alkene-containing polymer, combining the polymer with at least one homogeneous or heterogeneous transition metal olefin metathesis catalyst to form a polymeric or composite material, and performing an olefin metathesis reaction on the polymer so as to form reversible carbon-carbon double bonds in the polymer. Also provided is a method of healing a fractured surface of a polymeric material. The method includes bringing a fractured surface of a first polymeric material into contact with a second polymeric material, and performing an olefin metathesis reaction in the presence of a transition metal olefin metathesis catalyst such that the first polymeric material forms reversible carbon-carbon double bonds with the second polymeric material. Compositions comprising malleable and/or self-healing polymeric or composite material are also provided. | 2014-02-13 |
20140045998 | POLYOLEFIN COMPOSITIONS AND ARTICLES MANUFACTURED THEREFROM - The present invention is a polyolefin composition, which comprises a thermoplastic olefin polymer and a polyethylene. The thermoplastic olefin polymer (TPO) comprises a polypropylene and an olefin copolymer and is present in an amount of about 10 weight percent to about 50 weight percent; the TPO has a density in the range of about 0.85 g/cm | 2014-02-13 |
20140045999 | MEDICAL RUBBER - The present invention provides a medical rubber having high cleanliness and excellent compression set resistance. The present invention relates to a medical rubber including an ethylene-propylene-diene rubber crosslinked by an organic peroxide having no aromatic ring structure. | 2014-02-13 |
20140046000 | METHOD OF ACCELERATING THE CURING PROCESS IN RESIN OVERFLOW SYSTEMS FOR THE USE IN CASTING PROCESSES - A method of accelerating a curing process in resin overflow systems for use in casting processes includes the step of adding a curing accelerator for the resin into the resin overflow system. In addition, a resin overflow container and a compartment with a curing accelerator for use in casting processes are provided. | 2014-02-13 |
20140046001 | EPOXY SYSTEMS AND AMINE POLYMER SYSTEMS AND METHODS FOR MAKING THE SAME - Compositions and methods for forming surfactants, aqueous dispersions, and curing agents are provided. In one aspect, the invention relates to improved epoxy functional surfactants prepared by reaction of an epoxy composition and an amidoamine composition formed from a blend of acid-terminated polyoxyalkylene polyols. The improved epoxy functional surfactants may be reacted with an excess of epoxy composition and water to result in an aqueous dispersion. The amidoamine composition may be a reaction mixture of a diamine compound and an acid terminated polyoxyalkylene composition formed from two or more polyoxyalkylene polyol compounds. The epoxy functional surfactant may be reacted with amine compounds to form a compound suitable as a curing agent. | 2014-02-13 |